4.6 Article

Influence of dietary isoflavone intake on gastrointestinal symptoms in ulcerative colitis individuals in remission

Journal

WORLD JOURNAL OF GASTROENTEROLOGY
Volume 23, Issue 29, Pages 5356-5363

Publisher

BAISHIDENG PUBLISHING GROUP INC
DOI: 10.3748/wjg.v23.i29.5356

Keywords

Abdominal pain; Constipations ulcerative colitis; Daidzein; Genistein; Glycitein; Isoflavone

Funding

  1. Ministry of Science and Higher Education [WULS-SGGW: 505-10-100400-L00332-99/2014]

Ask authors/readers for more resources

AIM To analyse the association between isoflavone intake and ulcerative colitis motility symptoms in individuals in remission. METHODS Cross-sectional study was conducted in a group of ulcerative colitis remission individuals, in subgroups characterised by various intestinal motility and functioning characteristics (abdominal pain, flatulence, constipations, tenesmus). Total of 56 individuals with ulcerative colitis in remission (19 males and 37 females) were recruited for the study. Assessment of diet was based on self-reported data from each patient's dietary records taken over a period of three typical, random days (2 weekdays and 1 d of the weekend). The daily isoflavone intake (daidzein, genistein, glycitein and total isoflavones) and daily isoflavone intake per 1000 kcal of diet were assessed. RESULTS No correlations between isoflavone intake levels and number of bowel movements per day were observed both in the case of intake and intake per 1000 kcal of diet. In the group of individuals declaring lack of abdominal pain, the higher intakes of daidzein (p = 0.0075), daidzein per 1000 kcal of diet (p = 0.0358) and total isoflavone (p = 0.0358) were stated, than in the group of individuals declaring abdominal pain. In the group of individuals declaring lack of constipations, the lower intakes of glycitein (p = 0.0213) and glycitein per 1000 kcal of diet (p = 0.0213) were stated, than in the group of individuals declaring presence of constipations. No differences were observed in isoflavone intake between groups of ulcerative colitis individuals declaring lack of flatulence and declaring presence of flatulence, as well as between groups declaring lack of tenesmus and declaring presence of tenesmus. CONCLUSION The moderate dietary isoflavone intake may be beneficial for individuals with ulcerative colitis in remission, however, before including it into recommendations, further prospective studies are needed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available